![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Professor Gerard Evan (HOD Biochemistry), Angela Williams (Director Health Outcomes and Pharmacoeconomics, MedImmune) and Iain Scott (Senior Analyst, Ernst & Young) 
Thursday 14 March 2013, 18:30-20:00
Challenging the price of drugs
- đ¤ Speaker: Professor Gerard Evan (HOD Biochemistry), Angela Williams (Director Health Outcomes and Pharmacoeconomics, MedImmune) and Iain Scott (Senior Analyst, Ernst & Young)
- đ Date & Time: Thursday 14 March 2013, 18:30 - 20:00
- đ Venue: Pfizer Lecture Theatre Department of Chemistry Lensfield Road Cambridge Cambridgeshire CB2 3RA
Questions? Contact
Krishnaa Mahbubani
Abstract
Why does developing drugs cost so much? Why does it take so long? What is the difference between branded and generic drugs?
These questions are discussed by a panel including Professor Gerard Evan (HOD Biochemistry), Angela Williams (Director Health Outcomes and Pharmacoeconomics, MedImmune) and Iain Scott (Senior Analyst, Ernst & Young) whilst an understanding of drug development is established
Series This talk is part of the GBR talks series.
Included in Lists
- Cambridge Infectious Diseases
- GBR talks
- Pfizer Lecture Theatre Department of Chemistry Lensfield Road Cambridge Cambridgeshire CB2 3RA
Note: Ex-directory lists are not shown.